Latest News

Trial to Assess Dose Escalation of Experimental Drug Plus Immunotherapy in Solid Tumors Begins

January 18th 2022

By Jamie Cesanek

The STELLAR-002 trial is currently underway to examine the combination of XL092, an experimental tyrosine kinase inhibitor, in combination with immuno-oncology therapies for patients with advanced solid tumors.

Partner-Inclusive Interventions May Help Recover Sexual Intimacy After Prostate Cancer

January 17th 2022

By Brielle Benyon

Prostate cancer survivors are encouraged to include their partners in interventions to improve sexual function after treatment — and, as study results show, it is better to have these conversations with providers sooner rather than later.

FDA Speeds Up Review of Enhertu for Previously Treated Unresectable/Metastatic HER2-Breast Cancer

January 17th 2022

By Brielle Benyon

After the drug showed promising results in the DESTINY-Breast03 trial, the FDA granted Enhertu a priority review, meaning that it plans to make its approval decision on it by the end of the second quarter of 2022.

How Can We Get Young Women to Get Annual Mammograms?

January 17th 2022

By Bonnie Annis

One breast cancer survivor shares the experience she had with her daughters in trying to get them to understand the importance of participating in preventive screenings.

More Than 75% of Cancer Survivors, Patients Express Wanting Employers to Implement Vaccine Mandates, Other Safety Precautions Before Returning to In-Office Work

January 17th 2022

By Colleen Moretti

The survey results also showed that those who have received a cancer diagnosis have faced more setbacks when it comes to working during the pandemic, especially those of Black race or Hispanic ethnicity.

All News

Advice on Coping With Fears of the COVID-19 Omicron Variant From a Cancer Survivor

January 10th 2022

Ron Cooper

A cancer survivor offers tips on dealing with the mental gymnastics of wondering whether his COVID-19 vaccine will work against the omicron variant and how more isolation will affect his mental state.

How Bone Strengtheners Led to a Dental Care Nightmare for One Patient With Cancer

January 10th 2022

Kathryn Foster

A woman living with stage 4 cancer explains her painful experience with dental issues that came as a result of cancer treatment.

FDA Target Dates for Potential Cancer Drug Approvals in Early 2022

January 10th 2022

Brielle Benyon

The Food and Drug Administration is expected to decide on whether to approve certain cancer regimens within the first few months of the year. Here’s what patients with cancer should know.

Instead of New Year’s Resolutions, Make Commitments, Says a Cancer Survivor

January 9th 2022

Bonnie Annis

A cancer survivor explains her approach to New Year’s resolutions and how she plans to make her health a priority.

A Serendipitous Friendship: How My Daughter’s Chemo Nurse Became Her Best Friend After Cancer Treatment

January 8th 2022

Debbie Legault

A mother describes how her daughter formed an unlikely friendship with one of her chemo nurses after her treatment ended.

Calquence Linked to Fewer Heart-Related, Other Toxicities in Patients With CLL Than Imbruvica

January 7th 2022

Dylann Cohn-Emery

Treatment with Calquence resulted in fewer toxicities, including atrial fibrillation, flutter and hypertension, in patients with previously treated chronic lymphocytic leukemia, compared with Imbruvica treatment, according to findings from the analysis of a phase 3 trial.

Digital App May Help Relieve Stress, Depression, Fatigue in Cancer Survivors

January 7th 2022

Colleen Moretti

Cancer survivors may experience psychological side effects of cancer and can benefit from stress management interventions, although these in-person services are often limited.

‘Dear Body,’ A Tribute From a Cancer Survivor to Her Body

January 7th 2022

Tamera Anderson-Hanna

A breast cancer survivor describes a project she participated in — the Dear Body Project — to thank her body for all that it has endured.

Former MLB Pitcher Jim Corsi Dies After Cancer, Actress Brittany Daniel Uses Twin as Surrogate and More

January 7th 2022

Jamie Cesanek

From former Boston Red Sox pitcher Jim Corsi’s death after cancer to how “Sweet Valley High” actress Brittany Daniel’s unique experience after cancer caused pregnancy difficulties, here’s what’s happening in the cancer landscape this week.

New Drug Combo Boasts Improved Outcomes, Fewer Side Effects in Melanoma

January 7th 2022

Brielle Benyon

Relatlimab plus Opdivo improved progression-free survival in patients with untreated, advanced melanoma, and tended to have fewer side effects than other regimens used in this patient population.

Some Allergy Medications May Positively Influence Immunotherapy Responses in Cancer, But Is Only ‘A Tip of the Iceberg’

January 6th 2022

Darlene Dobkowski, MA

Certain allergy medications like Zyrtec and Claritin may be the key for more patients to tolerate immunotherapy for several cancer types.

Although Physicians Prefer Colonoscopy, Many Are Implementing Shared Decision-Making With Patients in Colon Cancer Screening

January 6th 2022

Jamie Cesanek

“It is frequently said that the best screening test is the one patients are willing to complete,” a researcher said. However, some experts note that colonoscopies are the gold standard for detecting and confirming colorectal cancer.

How I Learned to Live After Learning How to Die From Cancer

January 6th 2022

William Ramshaw

A pancreatic cancer survivor explains how he learned to live after cancer and reflects on lessons learned from the book, “Tuesdays with Morrie.”

Expert Explores the Relationship Between Down Syndrome and Leukemia

January 6th 2022

Jamie Cesanek

In this episode of the “Cancer Horizons” podcast, an expert unpacks cancer risks for individuals with Down syndrome and analyzes the results of a recent study about mortality risks for childhood survivors later in life.

Keytruda/Chemo Combo Is ‘Great News’ for Patients With TNBC, ‘But We Need Much More’

January 6th 2022

Jamie Cesanek

An expert discusses improvements in survival outcomes for patients with triple-negative breast cancer who received Keytruda plus chemotherapy — now considered the standard of care — but urges that more researched is always needed for this patient population.

Pillars of Support, Leaning on Each Other

January 6th 2022

In this feature, Tony and Jackie share how they stay positive and help others in the kidney cancer community.

Trial Underway to Assess Efficacy of Novel Radiopharmaceutical Drug in Neuroendocrine Tumors

January 5th 2022

Jamie Cesanek

The phase 3 COMPOSE trial will look at the efficacy of using 177lu-edotreotide — a novel radiopharmaceutical that is designed to limit radiation exposure to normal tissue — in patients with later stage neuroendocrine tumors.

Aromatase Inhibitors Reduce Recurrence Risk, But Not Death Rates, in Premenopausal Patients With Breast Cancer

January 5th 2022

Lindsay Fischer

Premenopausal women with ER-positive breast cancer experienced a decreased rate of recurrence when given an aromatase inhibitor, compared with those given tamoxifen. However, more research is still needed, an expert said.

Regardless of How Many New Year’s Resolutions People Make, A Patient With Cancer Advises Advocating for Oneself

January 5th 2022

Julie S. Brokaw

After a challenging year due to COVID-19 and rising blood test numbers, a woman living with ovarian cancer shares on what she’s learned and how she’s approaching 2022.

Upfront Darzalex Combo May Be More Beneficial in the First-Line Setting for Transplant-Ineligible Myeloma Than Alternatives

January 5th 2022

Jamie Cesanek

An expert from the Mayo Clinic explained that the use of a combination of drugs including Darzalex in the first-line setting may lead to better outcomes for patients with multiple myeloma instead of other first-line standard-of-care options.

Families and Caregivers Must 'Juggle' Between Risks and Benefits of Treating Children with Skin Cancer

January 5th 2022

Brielle Benyon

The recent FDA approval of Keytruda, an immunotherapy monoclonal antibody drug, for children with melanoma is an exciting development, according to an expert. But there is potential for certain side effects that children and their family should consider before undergoing treatment.

Go2 Foundation Expert Explains Who Should Be Screened for Lung Cancer and Why

January 4th 2022

Kristie L. Kahl

Angela Criswell, director of quality screening and program initiatives at GO2 Foundation for Lung Cancer, discusses early detection and screening for lung cancer.

Biomarker Testing Helps To ‘Identify the Typos in a Script’ Following a Lung Cancer Diagnosis

January 4th 2022

Kristie L. Kahl

Daniel Saez, treatment and trials navigator at the GO2 Foundation for Lung Cancer, discusses biomarker testing and precision medicine in lung cancer.

Combatting an Isolating Disease: An Expert Offers Lung Cancer Resources for Patients, Caregivers

January 4th 2022

Kristie L. Kahl

Susan Smedley, national manager of community fundraising and endurance events at GO2 Foundation for Lung Cancer, offers resources for patients with lung cancer and their loved ones, as well as ways to get involved in the community.

While QOL Preferences Can Be Different, Lung Cancer Resources Can Match Patient Needs

January 4th 2022

Kristie L. Kahl

Susan Smedley, national manager of community fundraising and endurance events at GO2 Foundation for Lung Cancer, discusses quality of life in lung cancer, and ways patients can communicate preferences to their health care providers.

2021’s Most-Read Childhood Cancer Stories

January 4th 2022

Brielle Benyon

From long-term effects of pediatric cancer to a survivor fulfilling her dream of being an astronaut, CURE® looked back on its most-read childhood cancer stories of the year.

Optimism Versus Realism When It Comes to Cancer

January 4th 2022

Kim Johnson

A sister of a woman with cancer writes about how the idea of recurrence faded to the back of her mind, but now she must be realistic about the future.

FDA Grants Speedy Review for Novel NSCLC Therapy

January 4th 2022

Brielle Benyon

The Food and Drug Administration will offer guidance and expedited review to CLN-081, a novel drug that is promising for the treatment of EGFR exon 20-mutated non-small cell lung cancer.

The Most-Read Myeloma Stories of 2021

January 4th 2022

Brielle Benyon

From an overview of the disease to notable deaths and clinicians who go the extra mile, here is a list of CURE®’s most-read myeloma articles from 2021.

Novel Drug Combo Induces Encouraging Results in Patients With Heavily Pretreated Breast Cancer

January 3rd 2022

Will Pizii

The use of Faslodex plus the investigational drug samuraciclib was considered safe in individuals with heavily pretreated hormone receptor-positive breast cancer.

See All News